1.
Bioorg Med Chem Lett
; 19(15): 4446-9, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19525110
RESUMO
A series of potent and orally bioavailable 3,4-diaminocyclobutenediones with various amide modifications and substitution on the left side phenyl ring were prepared and found to show significant inhibitory activities towards both CXCR2 and CXCR1 receptors.